Quick Answer
Nutex Health Inc. reported Operating Income Loss of $275.63 million for the year ending 2025.
- Nutex Health Inc. showed an increase of +110.9% in Operating Income Loss from 2024 to 2025.
- This data is from Nutex Health Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $204.8 thousand | Q1 2011: -$170.7 thousand | Q2 2011: -$194.8 thousand | Q3 2011: -$239.4 thousand | Q1 2012: -$271.6 thousand | Q2 2012: -$226.7 thousand | Q3 2012: -$184.9 thousand | Q1 2013: -$202.0 thousand | Q2 2013: -$166.2 thousand | Q3 2013: -$158.2 thousand | Q1 2014: -$135.0 thousand | Q2 2014: -$201.3 thousand | Q3 2014: -$184.3 thousand | Q1 2015: -$143.2 thousand | Q2 2015: -$86.8 thousand | Q3 2015: -$121.8 thousand | Q1 2016: -$161.9 thousand | Q2 2016: -$64.5 thousand | Q3 2016: -$75.7 thousand | Q1 2017: -$163.2 thousand | Q2 2017: -$1.25 million | Q3 2017: -$711.9 thousand | Q1 2018: -$412.0 thousand | Q2 2018: -$489.0 thousand | Q3 2018: -$367.0 thousand | Q1 2019: -$925.9 thousand | Q3 2019: -$906.1 thousand | Q1 2020: -$939.9 thousand | Q2 2020: $645.6 thousand | Q3 2020: $1.78 million | Q1 2021: -$4.15 million | Q2 2021: $27.60 million | Q3 2021: $74.46 million | Q1 2022: $29.24 million | Q2 2022: -$1.38 million | Q3 2022: -$428.68 million | Q4 2022: -$5.78 million | Q1 2023: -$4.45 million | Q2 2023: -$362.5 thousand | Q3 2023: -$821.2 thousand | Q4 2023: -$26.14 million | Q1 2024: $1.45 million | Q2 2024: $5.30 million | Q3 2024: $9.66 million | Q4 2024: $114.21 million | Q1 2025: $72.21 million | Q2 2025: $33.68 million | Q3 2025: $130.37 million.
- Over the full 16 years of available data (2010 to 2025), Nutex Health Inc.'s Operating Income Loss has grown by 20,574.1%.
- Historical annual values: Fiscal year 2025: $275.63 million | Fiscal year 2024: $130.70 million | Fiscal year 2023: -$31.77 million | Fiscal year 2022: -$406.60 million | Fiscal year 2021: $170.26 million | Fiscal year 2020: $153.17 million | Fiscal year 2019: -$6.90 million | Fiscal year 2018: -$840.4 thousand | Fiscal year 2017: -$5.69 million | Fiscal year 2016: -$448.6 thousand | Fiscal year 2015: -$533.0 thousand | Fiscal year 2014: -$723.4 thousand | Fiscal year 2013: -$727.4 thousand | Fiscal year 2012: -$1.57 million | Fiscal year 2011: -$844.6 thousand | Fiscal year 2010: -$1.35 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: